The effect of hydroxychloroquine and azithromycin combination treatment on T peak-end, QT, corrected QT intervals and T peak-end/QT and T peak-end/corrected QT ratios in patients with COVID-19

Ayhan Cosgun; Hüseyin Ören; Mustafa Turkkanı

doi:10.5455/im.63081

The effect of hydroxychloroquine and azithromycin combination treatment on T peak-end, QT, corrected QT intervals and T peak-end/QT and T peak-end/corrected QT ratios in patients with COVID-19

International Medicine ◽

10.5455/im.63081 ◽

2021 ◽

Vol 3 (4) ◽

pp. 110

Author(s):

Ayhan Cosgun ◽

Hüseyin Ören ◽

Mustafa Turkkanı

Keyword(s):

Combination Treatment ◽

Qt Intervals

Download Full-text

Psychiatric side effects during combination treatment for chronic hepatitis C with interferon-α and ribavirin in psychiatric risk groups—A prospective and controlled study

Gastroenterology ◽

10.1016/s0016-5085(01)82831-6 ◽

2001 ◽

Vol 120 (5) ◽

pp. A569-A570

Author(s):

M SCHAEFER ◽

F SCHMIDT ◽

M SOYKA ◽

R LORENZ ◽

K LOESCHKE ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Side Effects ◽

Chronic Hepatitis C ◽

Combination Treatment ◽

Risk Groups ◽

Controlled Study ◽

Interferon Α ◽

Psychiatric Side Effects

Download Full-text

Combination treatment of a novel activin receptor IIB ligand trap and zoledronate improves muscle and bone proprieties in a mouse model of osteogenesis imperfecta

Bone Abstracts ◽

10.1530/boneabs.7.oc12 ◽

2019 ◽

Author(s):

Iris Boraschi-Diaz ◽

Frank Rauch

Keyword(s):

Mouse Model ◽

Osteogenesis Imperfecta ◽

Combination Treatment ◽

Activin Receptor ◽

Activin Receptor Iib

Download Full-text

1907-P: GLP-1RA and iSGLT2 Combination Treatment Effects over Fatty Liver Index

Diabetes ◽

10.2337/db19-1907-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1907-P

Author(s):

JUANA CARRETERO GÓMEZ ◽

JOSE CARLOS AREVALO LORIDO ◽

RICARDO GÓMEZ-HUELGAS ◽

JOSÉ MIGUEL SEGUÍ-RIPOLL ◽

MANUEL SUAREZ TEMBRA ◽

...

Keyword(s):

Fatty Liver ◽

Combination Treatment ◽

Treatment Effects ◽

Liver Index ◽

Fatty Liver Index

Download Full-text

QT Intervals Correlate with Carotid Artery Intima Media Thickness in a Gender-Specific and Segment-Specific Manner in Asymptomatic Dyslipidemic Patients

Cardiology & Neurocardiovascular Diseases ◽

10.24966/cncd-8860/100005 ◽

2015 ◽

Vol 2 (1) ◽

pp. 1-5

Author(s):

Giuliana Mombelli ◽

Keyword(s):

Carotid Artery ◽

Intima Media Thickness ◽

Media Thickness ◽

Qt Intervals ◽

Specific Manner ◽

Gender Specific

Download Full-text

NON-SURGICAL MANAGEMENT OF A SEVERE SCALP WOUND WITH COMBINATION TREATMENT INCLUDING NEGATIVE PRESSURE THERAPY AND SKIN CELL SPRAY

10.26226/morressier.578e3b52d462b80292382cef ◽

2016 ◽

Author(s):

Baljinder Sandhu

Keyword(s):

Surgical Management ◽

Combination Treatment ◽

Negative Pressure ◽

Negative Pressure Therapy ◽

Pressure Therapy ◽

Skin Cell ◽

Scalp Wound

Download Full-text

Combination Treatment of Human Breast Cancer Cells with Possible RNAi Enhancer and siRNA Targeting Polo-Like Kinase 1

10.26226/morressier.57d6b2b8d462b8028d88d8f0 ◽

2016 ◽

Author(s):

Masahiro Hashimoto

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Combination Treatment ◽

Human Breast Cancer ◽

Breast Cancer Cells ◽

Human Breast Cancer Cells ◽

Human Breast

Download Full-text

Management of nocturia in patients with benign prostate enlargement and overactive bladder symptoms with Solifenacin and Tamsulosin combination treatment versus Tamsulosin monotherapy.

10.26226/morressier.59b63e41d462b8029238962d ◽

2017 ◽

Author(s):

Vasileios Sakalis

Keyword(s):

Overactive Bladder ◽

Combination Treatment ◽

Overactive Bladder Symptoms ◽

Prostate Enlargement ◽

Bladder Symptoms ◽

Benign Prostate

Download Full-text

Clinical efficacy of combination treatment for advanced-stage axial diabetic optic neuropathy

Oftalmologicheskii Zhurnal ◽

10.31288/oftalmolzh201853944 ◽

2018 ◽

Vol 76 (5) ◽

pp. 39-44

Author(s):

M. Karliychuk ◽

Keyword(s):

Clinical Efficacy ◽

Optic Neuropathy ◽

Combination Treatment ◽

Advanced Stage

Download Full-text

Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

Case Medical Research ◽

10.31525/ct1-nct04173507 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Gene Mutation ◽

Cell Lung Cancer ◽

Combination Treatment ◽

Stage Iv ◽

Small Cell ◽

Treatment Trial ◽

Small Cell Lung ◽

Stk11 Gene

Download Full-text

Faculty Opinions recommendation of Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.4957957.4890058 ◽

2010 ◽

Author(s):

Xavier Leleu

Keyword(s):

Phase Ii ◽

Multicenter Study ◽

Combination Treatment ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text